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A term infant required intubation for respiratory depression. Examination revealed hypotonia and areflexia with intact 
extraocular movements. Electrodiagnostic studies demonstrated defective neuromuscular transmission characterized by 
borderline low motor evoked amplitudes, profound decremental responses at all stimulation rates, and moderate 
facilitation (50 to 740%) 15 seconds after 5 seconds of 50 Hz stimulation. Repetitive muscle action potential responses 
were not recorded following stimulation of nerves by single shocks. Sensory evoked responses and needle electromyo- 
graphic findings were normal, as were acetylcholine receptor antibody levels. Results of muscle histochemical analyses, 
including acetylcholinesterase stains, were normal. End-plate histometric analyses demonstrated only a slight reduction 
in mean synaptic vesicle diameter compared with that in an adult control subject. In  vitro muscle contractile properties, 
stimulating the muscle directly, were normal. Anticholinesterase medications were ineffective. Guanidine produced 
clinical deterioration. The amplitude of motor evoked responses progressively declined, whereas the percentage of 
decrement and amount of post-tetanic facilitation increased. Although the nature of the transmission defect was not 
identified, the data are consistent with abnormal acetylcholine resynthesis, mobilization, or storage without abnormal- 
ity of release or receptors. 
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Numerous neuromuscular disorders that clinically re- 
semble myasthenia gravis have been described in neo- 
nates and infants. The  physiological abnormalities 
identified have led to a better understanding of 
neuromuscular transmission and are of great interest to 
the clinician {19}. We report a new infantile myas- 
thenic syndrome characterized by decrementai motor 
responses, prominent facilitation, and normal muscle 
structure and contractile properties without evidence 
of elevated acetylcholine receptor (AChR) antibody 
titers. 
Case Report 
A 3.3 kg term male infant was described as hypotonic with 
rare spontaneous movements and was noted to have intermit- 
tent apnea. The infant was transferred to Ann Arbor at 1 
week of age and required immediate intubation for respira- 
tory depression. Examination revealed diffuse weakness and 
areflexia with intact extraocular movements and pupillary 
reflexes. Episodic increases in spontaneous extremity move- 
ment and transient improvement in respiratory variables 
without assisted ventilation suggested defective neuromuscu- 
lar transmission. Nevertheless, repeated edrophonium and 
neostigmine tests were negative. Results of routine tests of 
serum, urine, and cerebrospinal fluid (CSF) were normal. 
Computed tomographic (CT) findings were normal, as was 
the initial electroencephalogram (EEG). Electroneuromyog- 
raphy at 2 weeks of age demonstrated a severe defect of 
neuromuscular transmission, to be described. At 3 weeks of 
age the infant had a ten-second episode of tonic-clonic ex- 
tremity movements. Repeat CSF examinations showed no 
abnormalities, although a repeat CT scan was suggestive of a 
subarachnoid hemorrhage. Later this finding was interpreted 
as delineation of the falx by the high-resolution scanner. Re- 
peat EEG was unchanged. Serum and stool botulinum toxin 
assays were negative, and AChR antibody titers were not 
elevated. Family history revealed consanguinity, the mother 
and father being first cousins. The patient was their only 
child. 
Throughout the next 3 months transient improvement was 
noted, frequently consisting of vigorous spontaneous extrem- 
ity and facial movements. Unassisted ventilation was possible 
for up to 4 hours, but mechanical ventilation was always 
reinstituted. By 3 months of age, active reflexes (fatigable) 
and unsustained ankle clonus supported the clinical impres- 
sion of superimposed upper motor neuron involvement, pre- 
sumably related to a superimposed hypoxic encephalopathy. 
Repeated trials of anticholinesterase medications were inef- 
fective. Guanidine produced clinical deterioration after three 
days of maintenance at 18 mg/kg/day. Discontinuation re- 
sulted in subjective clinical improvement several days later. 
Over the next few months spontaneous improvement was 
less evident, and the patient died at 8 months of age of pneu- 
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Fig I .  Ulnar compound muscle action potentials evoked 6.i su- 
pramuximul repetitive stirnulation at 2 to 50 Hz,  demonstrating 
a decremental response most prominent at the highest stimulation 
rates. 
monia. Postmortem examination demonstrated a chronic 
sagittal sinus thrombosis with a diffuse encephalopathy. 
Electrodiagnostic Studies 
Sensory and motor nerve conduction studies were per- 
formed using conventional techniques of supramaximal 
percutaneous nerve stimulation. Sensory nerve action 
potentials (SNAPs) were of normal amplitude. Con- 
duction velocity and distal latencies were normal for 
age. Compound muscle action potentials (CMAPs) 
were similarly normal, although the amplitudes were 
borderline low. Repetitive motor nerve stimulation re- 
cording from appropriate muscles demonstrated a pro- 
found decremental response for all nerves evaluated. 
The decrement was present at all rates of stimulation 
from 1 to 50 Hz, with the greatest decrement at the 
higher rates (Fig 1). With continued stimulation there 
was evidence of a mild repair in the decremental re- 
sponse (early dip phenomenon), although there was no 
evidence of an incremental response. By 2 months of 
age moderate facilitation (50 to 740%) of the initial 
CMAP amplitude was demonstrated 15 seconds after 5 
seconds of 50 Hz stimulation; the decremental re- 
sponse to repetitive stimulation persisted (Fig 2 ) .  The 
post-tetanic facilitation was present in all muscles 
tested. SNAPs did not demonstrate a decremental re- 
sponse to repetitive stimulation, and repetitive motor 
responses were never recorded following a single nerve 
stimulus. 




Fig 2. Ulnar, median, and peroneal compound muscle action po- 
tentials evoked b supramaximal 2 H z  stimuiation, befre and 
15 seconds afer J seconds of 50 Hz tetanic stimulation. Each re- 
cording represents three successive responses (initial response 
largest; third response smallest). 
unchanged, although conduction velocities increased 
appropriately with increasing age. CMAPs progres- 
sively declined in amplitude, and the percentage of 
decrement and amount of post-tetanic facilitation in- 
creased. Intravenously administered edrophonium had 
no apparent effect upon either. 
Concentric needle electromyography demonstrated 
only a paucity of motor unit action potentials 
(MUAPs). MUAPs that were activated by positional 
changes in the extremity or that occurred spontane- 
ously appeared normal. It was never possible to dem- 
onstrate unequivocally moment-to-moment variability 
in individual MUAP amplitude. Abnormal spontane- 
ous activity (fibrillation potentials or positive waves) 
were not observed during repeated examinations. 
In Vitro Studies 
All studies were performed on a biopsy specimen ob- 
tained at 3 months of age from the flexor carpi radialis 
muscle. 
Light Microscopy and Routine Histocbemistty 
The only abnormality noted on examination of frozen 
sections stained with the routine ATPase stain at pH 
9.4 was the presence of a few isolated small type I1 
fibers. There was no type grouping or large group at- 
rophy. Other fibers within the section had diameters 
ranging from 15 to 19 p, normal for the patient’s age. 
Modified trichrome as well as routine H&E stains re- 
vealed no abnormalities in the muscle fiber architec- 
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ture, a normal amount and distribution of connective 
tissue, and no inflammatory reaction. Nerves and mus- 
cle spindles visualized with the Goshgarian procedure 
191 were within normal limits. ~ ~ ~ ~ ~ ~ ~ i f i ~  esterase, 
cholinesterase, succinic dehydrogenase, phosphory~ase, 
and oil red O stains revealed no additional abnor- 
malities. 
Fig 3. Motor end-plate region without subjective abnormality. 
Asterisk indicate secondary synaptic clgts. Quantitative evalua- 
tion indicated a slightly but significantly reduced mean vesicle di- 
ameter compared with that in  an adult control, without dzTer- 
ences in mean nerve terminal area or number of synaptic vesicles 
per unit area. (N = sarcoplasmic nucleus; S = Schwann cell.) 
( X  16,000.) 
Electron Microscopy 
The biopsy specimen was fixed in 3% phosphate- 
buffered glutaraldehyde and processed for electron mi- 
croscopy by conventional techniques. End-plate re- 
gions were identified on 1 +m thick sections stained 
with toluidine blue. A total of nine end plates were 
studied in multiple thin sections through each end 
plate. Thin sections were stained with uranyl acetate 
and lead citrate and examined in a Zeiss 109 electron 
microscope. All end-plate regions identified were pho- 
tographed and analyzed. An image analyzer was used 
for histometric analyses of the nerve terminal area and 
the number of synaptic vesicles per unit nerve terminal 
area. The outer diameters of randomly selected synap- 
tic vesicles' (n = 287) were measured at X 102,000 
final magnification. Muscle fibers appeared ultrastruc- 
turally normal with the exception of focal smearing of 
the 2 band at the periphery of one fiber. Motor end 
plates were well developed without apparent abnor- 
mality (Fig 3). Comparison with muscle from an adult 
control subject revealed no significant difference in 
mean nerve terminal area or number of synaptic vesi- 
cles per unit nerve terminal area. The mean vesicle 
diameter was slightly but significantly reduced in the 
patient compared with the control (means t SDs, 717 
t 9 and 764 +- 10, respectively). 
End-Plate Acetylcbolinesterase 
Biopsy specimens frozen in OCT compound (Miles 
Laboratories) were sectioned at -20°C at 26 p thick- 
ness. Nerves and motor end plates were present in the 
biopsy material. Nonspecific esterase and AChE his- 
tochemical stains showed a dense reaction product in 
the region of motor end plates (Fig 4). Preincubation 
with esterase inhibitors blocked the reaction. 
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Fig  4. Acetylcholinesterase histochemical stain demonstrating a 
danse reaction product in the region of motor end plates. ( x 1,000 
before 35% reduction.) 
Fig  5 .  Autoradiogram made afer incubation of muscle with 
‘2’I-alpha-bungarotoxin, demonstrating that end plates con- 
tained receptors capable of binding toxin at 10- M. 
Demonstration of End-Plate AChR 
Frozen specimens maintained in liquid nitrogen were 
sectioned and placed on slides treated with lOmM 
EDTA and 0.5% gelatin. Sections were incubated for 
one hour with lo-’ M alpha-bungarotoxin (BTX) 
labeled with iodine-125, 166 pCi/pg, in phosphate- 
buffered saline containing 1 % bovine serum albumin 
at room temperature. Control sections were incubated 
in a similar concentration of unlabeled BTX to evaluate 
nonspecific labeling. Sections were then fixed in 
Bouin’s fixative and counterstained with H&E. Labeled 
and fixed sections were dipped in NTB 3 emulsion 
(Kodak), dried, and stored at 4°C for 1 week prior to 
development in Dektol (1 : 1) (Kodak) for 5 minutes at 
20°C. 
Sections were examined with a Leitz phase-fluores- 
cence microscope and photographed. The 12’I-BTX- 
labeled slides demonstrated that end plates contained 
AChRs capable of binding toxin at lo-’ M (Fig 5). The 
grain distribution and density were subjectively nor- 
mal. Incubation of the specimen in unlabeled BTX 
prior to labeling with iodinated toxin resulted in an 
absence of labeling. Because of the lack of age-matched 
controls, it was not possible to make quantitative state- 
ments regarding the number of AChRs present. 
In Vitro M u d e  Contractile Properties 
A 600 mg fresh specimen was placed in cooled (5 to 
10°C) oxygenated Krebs’s bicarbonate saline. Samples 
were pinned in a dissection dish and covered with oxy- 
genated saline at room temperature. Excitable tissue 
was identified with stimulating electrodes. Two bun- 
dles of excitable fibers, 18 and 22 mm long and approx- 
imately 30 mg in mass, were dissected free and ligated 
at both ends. Both preparations were composed of seg- 
ments with fibers cut at both ends. Valid measurements 
of contractile properties can be obtained from fiber 
segments f71. 
Preparations were mounted between platinum 
stimulating electrodes in a muscle bath of 30 ml of 
Krebs’s bicarbonate saline with 10 mM of glucose and 
2 mg/dl tubocurarine chloride, perfused with 5% car- 
bon dioxide in oxygen, and maintained at 36 to 37°C. 
Preparations were stimulated with pulses of 40 and 100 
ps duration. Muscle bundle length was adjusted to give 
maximum isometric twitch tension. Stimulation rates of 
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1 ,  10, 20, 50, and 80 Hz were used to elicit maximum 
tetanic tension. 
Following measurement of contractile properties, a 
cross-sectioned specimen was prepared and frozen in 
isopentane cooled to its freezing point with liquid 
nitrogen. Sections were incubated for myofibrillar 
ATPase activity at p H  7.4. Fiber cross-sectional areas 
were obtained by planimetry. On the basis of low or 
high myofibrillar ATPase activity, muscle fibers were 
classified as type I or type 11, respectively. The per- 
centages of type I and type I1 fibers and the mean fiber 
area of each type were used to calculate the percentage 
of the cross-sectional area occupied by each fiber type. 
The maximum isometric tetanus tension ranged 
from 21 to 33 gm, with a twitch tension ratio of 0.21. 
The range for contraction times for bundles of fibers 
from human skeletal muscles is 5 5  to 140 ms C31. Be- 
cause 70% of the cross-sectional area of the bundles 
was composed of type I1 fibers, the contraction time 
would be expected to be at the fast end of the spec- 
trum. The experimentally obtained values of 60 and 67 
ms for contraction time and 40 and 46 ms for half- 
relaxation time are within the normal range for this 
composition of muscle fibers. Similarly, the force- 
frequency relationship was not different from control 
values for human muscles of comparable composition. 
We conclude that all of the contractile properties 
measured were within the normal range. 
Discussion 
Several terms are used to describe the variety of dis- 
eases of infancy causing muscle weakness and charac- 
terized by abnormal neuromuscular transmission. The 
terms include myasthenia gravis, myasthenia, and myas- 
thenic syndrome, often in association with a descriptor 
indicating time of onset. 
Transient neonatal myasthenia gravis is restricted to 
infants born to mothers with myasthenia gravis 181. 
The weakness is characteristic of that seen in classic 
myasthenia gravis but is transitory in the newborn pe- 
riod and presumably is related to passive transfer of 
maternal AChR antibody 1171. Transient neonatal my- 
asthenia gravis develops within the first 4 days of life, 
and AChR antibody titers are elevated in both mother 
and infant { 2 ,  141. 
Some congenital (hereditary) myasthenic syndromes 
are characterized by prominent ophthalmoplegia with 
onset during or within 2 years of the neonatal period 
117, 201. The impairment is not progressive, and 
AChR antibodies have not been detected. A decre- 
mental motor response was reported in three of five 
patients with congenital myasthenia, although the re- 
sults of in vitro electrophysiological studies suggested 
that the patients represented a heterogeneous group, 
some having presynaptic and others postsynaptic ab- 
normalities 1201. 
Familial infantile myasthenia is probably transmitted 
by autosomal recessive inheritance. It is often associ- 
ated with respiratory depression and feeding difficulties 
at birth, with little or no ophthalmoplegia. Episodic 
weakness and apnea may be noted during the first 2 
years of life, with subsequent improvement [ l ,  16, 171. 
Involvement of siblings is common. Abnormal im- 
mune mechanisms have not been reported. A decre- 
mental motor response may be present only after ex- 
ercise [lo, 161. Electrophysiological findings are con- 
sistent with a presynaptic defect of ACh synthesis or 
mobilization 1 10 1. 
A myasthenic syndrome characterized by general- 
ized weakness, hyporeflexia, and refractoriness to anti- 
cholinesterase medications has been described, with 
ptosis beginning shortly after birth 151. A decremental 
motor response was present at all stimulation rates, and 
a repetitive response was reported to single nerve 
stimulation. Several synaptic abnormalities were iden- 
tified. AChE was absent from all motor end plates. The 
average nerve terminal size was decreased, and some 
end plates had abnormal postsynaptic folds. The mean 
store of immediately releasable quanta was reduced. 
Neither the repetitive motor response, nor absent 
AChE, nor abnormal postsynaptic folds were present 
in the patient we report. 
Another reported congenital myasthenic syndrome 
was associated with ophthalmoparesis, variable extrem- 
ity involvement, a decremental motor response, and 
repetitive muscle action potentials to single nerve 
stimulus [6}. The average nerve terminal size was one- 
third less than normal, with increased synaptic vesicle 
density, and there was focal degeneration of junctional 
folds, with loss of AChR. AChE activity was present at 
end plates. The ultrastructural and electrophysiological 
findings were consistent with a neuromuscular trans- 
mission defect secondary to changes in end-plate ultra- 
structure, resulting from a prolonged open time of the 
ACh-induced ion channel. 
A familial, congenital myasthenic syndrome with a 
possible abnormality of AChR synthesis or incorpora- 
tion in the postsynaptic membrane has been described 
in a young adult with a similarly affected sibling 113, 
201. One of these patients 1131 had had ptosis, limb 
weakness, and abnormal fatigability since birth. AChR 
antibodies were not present, although the muscle con- 
tent of AChRs was low. Results of electrodiagnostic 
evaluation were characteristic of those expected in ac- 
quired autoimmune myasthenia gravis. 
The patient we describe is not readily classifiable into 
any of the categories discussed. Although he was an 
only child, the consanguinity suggests a congenital ab- 
normality. The mother was asymptomatic, and neither 
the mother nor the infant had detectable AChR anti- 
bodies. Respiratory and extremity weakness pre- 
dominated. Extraocular movements were full, making a 
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clinical diagnosis of congenital (hereditary) myasthenia 
gravis unlikely. 
The results of the electrodiagnostic studies were un- 
characteristic of previously reported disorders 1 191. 
The decremental motor response was profound (49 to 
90%) and present at all rates (1 to 50 Hz) of motor 
nerve stimulation, and there was partial repair of the 
decrement during continued stimulation (as opposed to 
a progressive decrement), consistent with the response 
expected in myasthenia gravis 1 151. The decrement in- 
creased at higher rates of stimulation, a finding ex- 
pected if the immediately available store of ACh was 
decreasing and ACh mobilization could not keep up 
with release. The eventual stabilization of the CMAPs 
with continuous stimulation represents an equilibrium 
between mobilization and release. A progressive de- 
cline in the CMAPs may be present in some healthy 
newborns, particularly at high rates of stimulation 112). 
In our patient both the abnormally low CMAP am- 
plitude and the decremental motor response were pro- 
gressive and cannot be attributed to an immature 
neuromuscular junction. The decremental response 
alone could be seen in association with myotonia and 
was prolonged after depolarization, but myotonia was 
not demonstrated on needle electromyography and 
would not account for the reduced CMAP amplitude 
prior to repetitive stimulation. 
Failure of repetitive motor nerve stimulation at high 
rates to facilitate the CMAP amplitude suggests that 
calcium-mediated ACh release was not abnormal. This 
finding is also consistent with both the failure of 
guanidine to improve neuromuscular transmission and 
the absence of facilitation immediately after tetanic 
stimulation. 
Prominent facilitation of the CMAPs was observed 
approximately 15 seconds after brief tetanic stimula- 
tion. The time course of facilitation was unlike that 
reported for some patients with myasthenia gravis [18), 
in whom an incremental response can be demonstrated 
immediately after voluntary tetanus or during electrical 
stimulation. Tetanic stimulation increases ACh mobili- 
zation 14, 111. Mobilization continues for several sec- 
onds after tetanic stimulation, and the releasable store 
of ACh may be increased 1191, perhaps explaining the 
substantial facilitation in CMAPs observed in our 
patient. 
The slight but significant difference in mean vesicle 
diameter identified in histometric analyses of the pa- 
tient end-plate region compared with that in an adult 
control is of unknown significance. It may reflect nor- 
mal size for age, as opposed to faulty synaptic vesicle 
development . 
The defect in neuromuscular transmission could be 
explained by abnormal ACh resynthesis, mobilization, 
or storage, without abnormality of ACh release or of 
AChRs. In a model in which the releasable store of 
ACh was low, the end-plate potential for many muscle 
fibers could be below threshold for excitation of the 
muscle fiber action potential, and the CMAP would be 
reduced. Repetitive stimulation at low rates prior to 
mobilization would further deplete the releasable store 
and reduce the CMAP. Mobilization of ACh would 
augment the releasable store and partially repair or 
stabilize the decrement. Stimulation at higher rates (20 
to 50 Hz) would result in a more rapid depletion of the 
already reduced releasable store and a greater reduc- 
tion in the CMAP amplitude. The facilitative effects of 
calcium would be small in such a hypothetical model, 
with the result being simply the release of a larger 
percentage of an inadequate ACh store. Persistent 
ACh mobilization several seconds after tetanic stimula- 
tion would result in “overfilling” of the releasable store 
{ 191, increased amplitude of end-plate potentials, and a 
short-lived increase in CMAP amplitude. In vitro mi- 
croelectrode studies would be necessary to define the 
neuromuscular transmission defect more precisely. 
Portions of this study were presented at the Annual Meeting of the 
American Association of Electromyography and Electrodiagnosis, 
Portland, OR, Oct 2, 1981, and at the Annual Meeting of the Myas- 
thenia Gravis Association, New York, NY, Dec 4, 1981. 
Many individuals participated in the evaluation and care of this pa- 
tient. The authors particularly thank Drs G. w. Goldstein and s. M. 
Donn for their assistance. 
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